vs

Side-by-side financial comparison of O’Reilly Automotive (ORLY) and Stryker Corporation (SYK). Click either name above to swap in a different company.

Stryker Corporation is the larger business by last-quarter revenue ($7.2B vs $4.4B, roughly 1.6× O’Reilly Automotive). O’Reilly Automotive runs the higher net margin — 13.7% vs 11.8%, a 1.9% gap on every dollar of revenue. On growth, Stryker Corporation posted the faster year-over-year revenue change (11.4% vs 7.8%). Stryker Corporation produced more free cash flow last quarter ($1.9B vs $364.5M). Over the past eight quarters, Stryker Corporation's revenue compounded faster (16.9% CAGR vs 5.4%).

O'Reilly Automotive, Inc., doing business as O'Reilly Auto Parts, is an American automotive part retailer that provides automotive parts, tools, supplies, equipment, and accessories to professional service providers and do-it-yourself customers. Founded in 1957 by the O’Reilly family, O'Reilly Auto Parts operates more than 6,400 stores in 48 states, Puerto Rico, Mexico, and Canada.

The Stryker is a family of eight-wheeled armored fighting vehicles derived from the Canadian LAV III, which in turn derived from the Swiss Mowag Piranha. Stryker vehicles are produced by General Dynamics Land Systems-Canada (GDLS-C) for the United States Army in a plant in London, Ontario. It has four-wheel drive (8×4) and can be switched to all-wheel drive (8×8).

ORLY vs SYK — Head-to-Head

Bigger by revenue
SYK
SYK
1.6× larger
SYK
$7.2B
$4.4B
ORLY
Growing faster (revenue YoY)
SYK
SYK
+3.6% gap
SYK
11.4%
7.8%
ORLY
Higher net margin
ORLY
ORLY
1.9% more per $
ORLY
13.7%
11.8%
SYK
More free cash flow
SYK
SYK
$1.5B more FCF
SYK
$1.9B
$364.5M
ORLY
Faster 2-yr revenue CAGR
SYK
SYK
Annualised
SYK
16.9%
5.4%
ORLY

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ORLY
ORLY
SYK
SYK
Revenue
$4.4B
$7.2B
Net Profit
$605.2M
$849.0M
Gross Margin
51.8%
64.5%
Operating Margin
18.8%
25.2%
Net Margin
13.7%
11.8%
Revenue YoY
7.8%
11.4%
Net Profit YoY
9.8%
55.5%
EPS (diluted)
$-8.01
$2.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ORLY
ORLY
SYK
SYK
Q4 25
$4.4B
$7.2B
Q3 25
$4.7B
$6.1B
Q2 25
$4.5B
$6.0B
Q1 25
$4.1B
$5.9B
Q4 24
$4.1B
$6.4B
Q3 24
$4.4B
$5.5B
Q2 24
$4.3B
$5.4B
Q1 24
$4.0B
$5.2B
Net Profit
ORLY
ORLY
SYK
SYK
Q4 25
$605.2M
$849.0M
Q3 25
$725.9M
$859.0M
Q2 25
$668.6M
$884.0M
Q1 25
$538.5M
$654.0M
Q4 24
$551.1M
$546.0M
Q3 24
$665.5M
$834.0M
Q2 24
$622.8M
$825.0M
Q1 24
$547.2M
$788.0M
Gross Margin
ORLY
ORLY
SYK
SYK
Q4 25
51.8%
64.5%
Q3 25
51.9%
63.6%
Q2 25
51.4%
63.8%
Q1 25
51.3%
63.8%
Q4 24
51.3%
64.9%
Q3 24
51.6%
64.0%
Q2 24
50.7%
63.0%
Q1 24
51.2%
63.6%
Operating Margin
ORLY
ORLY
SYK
SYK
Q4 25
18.8%
25.2%
Q3 25
20.7%
18.7%
Q2 25
20.2%
18.5%
Q1 25
17.9%
14.3%
Q4 24
18.0%
9.0%
Q3 24
20.5%
19.7%
Q2 24
20.2%
19.4%
Q1 24
18.9%
18.5%
Net Margin
ORLY
ORLY
SYK
SYK
Q4 25
13.7%
11.8%
Q3 25
15.4%
14.2%
Q2 25
14.8%
14.7%
Q1 25
13.0%
11.1%
Q4 24
13.5%
8.5%
Q3 24
15.2%
15.2%
Q2 24
14.6%
15.2%
Q1 24
13.8%
15.0%
EPS (diluted)
ORLY
ORLY
SYK
SYK
Q4 25
$-8.01
$2.20
Q3 25
$0.85
$2.22
Q2 25
$0.78
$2.29
Q1 25
$9.35
$1.69
Q4 24
$9.50
$1.41
Q3 24
$11.41
$2.16
Q2 24
$10.55
$2.14
Q1 24
$9.20
$2.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ORLY
ORLY
SYK
SYK
Cash + ST InvestmentsLiquidity on hand
$193.8M
$4.0B
Total DebtLower is stronger
Stockholders' EquityBook value
$-763.4M
$22.4B
Total Assets
$16.5B
$47.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ORLY
ORLY
SYK
SYK
Q4 25
$193.8M
$4.0B
Q3 25
$204.5M
$3.3B
Q2 25
$198.6M
$2.4B
Q1 25
$191.2M
$2.3B
Q4 24
$130.2M
$3.7B
Q3 24
$115.6M
$3.9B
Q2 24
$145.0M
$1.9B
Q1 24
$89.3M
$2.3B
Stockholders' Equity
ORLY
ORLY
SYK
SYK
Q4 25
$-763.4M
$22.4B
Q3 25
$-894.7M
$21.8B
Q2 25
$-1.2B
$21.2B
Q1 25
$-1.4B
$20.9B
Q4 24
$-1.4B
$20.6B
Q3 24
$-1.4B
$20.1B
Q2 24
$-1.6B
$19.8B
Q1 24
$-1.4B
$19.2B
Total Assets
ORLY
ORLY
SYK
SYK
Q4 25
$16.5B
$47.8B
Q3 25
$16.3B
$47.1B
Q2 25
$15.8B
$46.3B
Q1 25
$15.3B
$46.0B
Q4 24
$14.9B
$43.0B
Q3 24
$14.6B
$43.8B
Q2 24
$14.4B
$39.1B
Q1 24
$14.2B
$39.4B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ORLY
ORLY
SYK
SYK
Operating Cash FlowLast quarter
$633.5M
$2.1B
Free Cash FlowOCF − Capex
$364.5M
$1.9B
FCF MarginFCF / Revenue
8.3%
26.1%
Capex IntensityCapex / Revenue
6.1%
3.7%
Cash ConversionOCF / Net Profit
1.05×
2.52×
TTM Free Cash FlowTrailing 4 quarters
$1.6B
$4.3B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ORLY
ORLY
SYK
SYK
Q4 25
$633.5M
$2.1B
Q3 25
$616.5M
$1.5B
Q2 25
$756.8M
$1.1B
Q1 25
$755.1M
$250.0M
Q4 24
$624.5M
$1.9B
Q3 24
$772.0M
$1.5B
Q2 24
$948.9M
$633.0M
Q1 24
$704.2M
$204.0M
Free Cash Flow
ORLY
ORLY
SYK
SYK
Q4 25
$364.5M
$1.9B
Q3 25
$304.4M
$1.4B
Q2 25
$456.1M
$928.0M
Q1 25
$468.2M
$127.0M
Q4 24
$334.0M
$1.7B
Q3 24
$513.7M
$1.3B
Q2 24
$723.5M
$481.0M
Q1 24
$455.0M
$37.0M
FCF Margin
ORLY
ORLY
SYK
SYK
Q4 25
8.3%
26.1%
Q3 25
6.5%
22.3%
Q2 25
10.1%
15.4%
Q1 25
11.3%
2.2%
Q4 24
8.2%
25.9%
Q3 24
11.8%
23.7%
Q2 24
16.9%
8.9%
Q1 24
11.4%
0.7%
Capex Intensity
ORLY
ORLY
SYK
SYK
Q4 25
6.1%
3.7%
Q3 25
6.6%
3.1%
Q2 25
6.6%
3.0%
Q1 25
6.9%
2.1%
Q4 24
7.1%
4.1%
Q3 24
5.9%
3.1%
Q2 24
5.3%
2.8%
Q1 24
6.3%
3.2%
Cash Conversion
ORLY
ORLY
SYK
SYK
Q4 25
1.05×
2.52×
Q3 25
0.85×
1.79×
Q2 25
1.13×
1.26×
Q1 25
1.40×
0.38×
Q4 24
1.13×
3.54×
Q3 24
1.16×
1.77×
Q2 24
1.52×
0.77×
Q1 24
1.29×
0.26×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ORLY
ORLY

DIY Customer$2.2B49%
Professional Service Provider Customer$2.1B49%
Other Customers And Sales Adjustments$84.4M2%

SYK
SYK

Medical$1.3B18%
Endoscopy$1.1B16%
Traumaand Extremities$1.1B15%
Instruments$925.0M13%
Knees$749.0M10%
Neuro Cranial$669.0M9%
Neurovascular$539.0M8%
Hips$499.0M7%
Other Orthopaedics$267.0M4%
Spine$8.0M0%

Related Comparisons